Flash FinanceUS
Market closed S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · IDEX (IEX)

IDEX Q4 sales rise 9% to $863 million; full-year diluted EPS falls 15% to $6.64

Mixed Impact 3 of 5 earnings Written later

IDEX reported fourth-quarter 2024 net sales of $863 million, up 9%, and diluted EPS of $1.62, up 13%. For full year 2024, sales were flat at $3.3 billion and diluted EPS fell 15% to $6.64, and the company projected 2025 organic sales growth of 1% to 3% with GAAP diluted EPS of $6.56 to $6.96.

Key points

  • Q4 2024 net sales $863 million, up 9% overall and 3% organically; adjusted diluted EPS $2.04, up 11%
  • Full-year 2024 net sales $3.3 billion, flat overall and down 2% organically; diluted EPS $6.64, down 15%
  • 2025 outlook: full-year GAAP diluted EPS $6.56 to $6.96; first-quarter 2025 organic sales projected to decline 3% to 4%
  • Full-year 2024 operating cash flow $668 million, down 7%; free cash flow $603 million, down 4%

The filing

CompanyIDEX (IEX)
Form8-K, current report
Filed with the SECFeb 4, 2025, 4:30 PM ET
Accession number0000832101-25-000005

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:11 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 04, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.